Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 103
Filter
1.
PLoS One ; 19(7): e0306741, 2024.
Article in English | MEDLINE | ID: mdl-38980850

ABSTRACT

There has been much evidence showing the repercussions of prenatal bisphenol A (BPA) exposure with a postnatal high fat-diet (HFD) on offspring's health. However, the information on how the interaction between these two variables affects the gut microbiome is rather limited. Hence, we investigated the impact of a postnatal trans fat diet (TFD) on the gut microbiome of offspring exposed to BPA during the prenatal period in an animal model. Pregnant rats were divided into 5 mg/kg/day BPA, vehicle Tween80 (P80) or control (CTL) drinking water until delivery (N = 6 per group). Then, weaned male pups were further subdivided into three normal diet (ND) groups (CTLND, P80ND, and BPAND) and three TFD groups (CTLTFD, P80TFD, and BPATFD) (n = 6 per group). 180-250 g of faecal samples were collected on days 50 and 100 to assess the composition of the offspring's intestinal flora using next-generation sequencing. The alpha diversity indices of TFD offspring with and without BPA were markedly lower than their ND counterparts (p<0.001-p<0.05). The beta diversity, hierarchical cluster and network analyses of the offspring's microbiome demonstrated that the microbiome species of the TFD group with and without BPA were distinctly different compared to the ND group. Consistently, TFD and ND offspring pairings exhibited a higher number of significantly different species (p<0.0001-p<0.05) compared to those exposed to prenatal BPA exposure and different life stages comparisons, as shown by the multivariate parametric analysis DESeq2. Predictive functional profiling of the offspring's intestinal flora demonstrated altered expressions of genes involved in metabolic pathways. In summary, the gut flora composition of the rat offspring may be influenced by postnatal diet instead of prenatal exposure to BPA. Our data indicate the possibility of perturbed metabolic functions and epigenetic modifications, in offspring that consumed TFD, which may theoretically lead to metabolic diseases in middle or late adulthood. Further investigation is necessary to fully understand these implications.


Subject(s)
Benzhydryl Compounds , Gastrointestinal Microbiome , Phenols , Prenatal Exposure Delayed Effects , Animals , Gastrointestinal Microbiome/drug effects , Benzhydryl Compounds/toxicity , Phenols/toxicity , Female , Pregnancy , Rats , Prenatal Exposure Delayed Effects/microbiology , Prenatal Exposure Delayed Effects/chemically induced , Male , Diet, High-Fat/adverse effects , Rats, Sprague-Dawley , Feces/microbiology
2.
Cell Host Microbe ; 32(7): 1192-1206.e5, 2024 Jul 10.
Article in English | MEDLINE | ID: mdl-38955186

ABSTRACT

The impact of gestational diabetes mellitus (GDM) on maternal or infant microbiome trajectory remains poorly understood. Utilizing large-scale longitudinal fecal samples from 264 mother-baby dyads, we present the gut microbiome trajectory of the mothers throughout pregnancy and infants during the first year of life. GDM mothers had a distinct microbiome diversity and composition during the gestation period. GDM leaves fingerprints on the infant's gut microbiome, which are confounded by delivery mode. Further, Clostridium species positively correlate with a larger head circumference at month 12 in male offspring but not females. The gut microbiome of GDM mothers with male fetuses displays depleted gut-brain modules, including acetate synthesis I and degradation and glutamate synthesis II. The gut microbiome of female infants of GDM mothers has higher histamine degradation and dopamine degradation. Together, our integrative analysis indicates that GDM affects maternal and infant gut composition, which is associated with sexually dimorphic infant head growth.


Subject(s)
Diabetes, Gestational , Feces , Gastrointestinal Microbiome , Female , Humans , Diabetes, Gestational/microbiology , Pregnancy , Male , Infant , Feces/microbiology , Head/microbiology , Adult , Infant, Newborn , Clostridium/growth & development , Prenatal Exposure Delayed Effects/microbiology
3.
Sci Rep ; 14(1): 16121, 2024 07 12.
Article in English | MEDLINE | ID: mdl-38997303

ABSTRACT

Microbiota imbalances are linked to inflammation and disease, as well as neurodevelopmental conditions where they may contribute to behavioral, physiological, and central nervous system dysfunction. By contrast, the role of the microbiota in Fetal Alcohol Spectrum Disorder (FASD), the group of neurodevelopmental conditions that can occur following prenatal alcohol exposure (PAE), has not received similar attention. Here we utilized a rodent model of alcohol consumption during pregnancy to characterize the impact of alcohol on the microbiota of dam-offspring dyads. Overall, bacterial diversity decreased in alcohol-consuming dams and community composition differed from that of controls in alcohol-consuming dams and their offspring. Bacterial taxa and predicted biochemical pathway composition were also altered with alcohol consumption/exposure; however, there was minimal overlap between the changes in dams and offspring. These findings illuminate the potential importance of the microbiota in the pathophysiology of FASD and support investigation into novel microbiota-based interventions.


Subject(s)
Alcohol Drinking , Feces , Prenatal Exposure Delayed Effects , Animals , Pregnancy , Female , Feces/microbiology , Alcohol Drinking/adverse effects , Prenatal Exposure Delayed Effects/microbiology , Rats , Fetal Alcohol Spectrum Disorders/microbiology , Gastrointestinal Microbiome/drug effects , Ethanol/adverse effects , Male , Disease Models, Animal , Microbiota/drug effects , Bacteria/classification , Bacteria/drug effects
5.
Sci Rep ; 14(1): 13762, 2024 06 14.
Article in English | MEDLINE | ID: mdl-38877103

ABSTRACT

Selective Serotonin Reuptake Inhibitor (SSRI) therapy is common among perinatal populations for the treatment of mood disorders. Medications can affect diversity and composition of the gut microbiome, which plays a key role in modulating health. While previous studies have examined the effects of antidepressant exposure on the maternal gut microbiome, whether SSRI exposure affects the offspring gut microbiome is unknown. We investigated the effects of maternal fluoxetine exposure on the gut microbiome of maternal and offspring mice during pregnancy and lactation (embryonic day 10-lactation day 21; E10-L21). Stool samples collected on E17, L11, L15, and L21 were examined using 16S rRNA sequencing. Our results suggest that maternal fluoxetine exposure may result in decreased alpha diversity of the offspring gut microbiome in early life. Furthermore, we observed several genera-specific differences in the gut microbiome based on treatment, specifically of Turicibacter, Parasutterella, and Romboutsia. These findings support our understanding of gut health, as dysbiotic development of the gut microbiome has been associated with local and systemic health problems including gastrointestinal morbidities and interrupted growth patterns in infants. Future research should pursue study in human populations and those at high risk for gut microbial dysbiosis and intestinal injury.


Subject(s)
Fluoxetine , Gastrointestinal Microbiome , Lactation , RNA, Ribosomal, 16S , Animals , Gastrointestinal Microbiome/drug effects , Female , Pregnancy , Lactation/drug effects , Fluoxetine/pharmacology , Fluoxetine/adverse effects , Mice , RNA, Ribosomal, 16S/genetics , Prenatal Exposure Delayed Effects/microbiology , Selective Serotonin Reuptake Inhibitors/adverse effects , Selective Serotonin Reuptake Inhibitors/pharmacology , Feces/microbiology , Maternal Exposure/adverse effects , Bacteria/drug effects , Bacteria/classification , Bacteria/genetics , Bacteria/isolation & purification
6.
Environ Res ; 257: 119283, 2024 Sep 15.
Article in English | MEDLINE | ID: mdl-38830395

ABSTRACT

BACKGROUND: Animal and human studies indicate that exposure to air pollution and natural environments might modulate the gut microbiota, but epidemiological evidence is very scarce. OBJECTIVES: To assess the potential impact of pre- and postnatal exposure to air pollution and green spaces on infant gut microbiota assembly and trajectories during the first year of life. METHODS: MAMI ("MAternal MIcrobes") birth cohort (Valencia, Spain, N = 162) was used to study the impact of environmental exposure (acute and chronic) on infant gut microbiota during the first year of life (amplicon-based 16S rRNA sequencing). At 7 days and at 1, 6 and 12 months, residential pre- and postnatal exposure to air pollutants (NO2, black carbon -BC-, PM2.5 and O3) and green spaces indicators (NDVI and area of green spaces at 300, 500 and 1000 m buffers) were obtained. For the association between exposures and alpha diversity indicators linear regression models (cross-sectional analyses) and mixed models, including individual as a random effect (longitudinal analyses), were applied. For the differential taxon analysis, the ANCOM-BC package with a log count transformation and multiple-testing corrections were used. RESULTS: Acute exposure in the first week of life and chronic postnatal exposure to NO2 were associated with a reduction in microbial alpha diversity, while the effects of green space exposure were not evident. Acute and chronic (prenatal or postnatal) exposure to NO2 resulted in increased abundance of Haemophilus, Akkermansia, Alistipes, Eggerthella, and Tyzerella populations, while increasing green space exposure associated with increased Negativicoccus, Senegalimassilia and Anaerococcus and decreased Tyzzerella and Lachnoclostridium populations. DISCUSSION: We observed a decrease in the diversity of the gut microbiota and signs of alteration in its composition among infants exposed to higher levels of NO2. Increasing green space exposure was also associated with changes in gut microbial composition. Further research is needed to confirm these findings.


Subject(s)
Air Pollution , Gastrointestinal Microbiome , Gastrointestinal Microbiome/drug effects , Humans , Female , Infant , Spain , Air Pollution/adverse effects , Infant, Newborn , Air Pollutants/analysis , Air Pollutants/toxicity , Birth Cohort , Male , Environmental Exposure/adverse effects , Pregnancy , Cohort Studies , Maternal Exposure/adverse effects , Prenatal Exposure Delayed Effects/microbiology
7.
Gut Microbes ; 16(1): 2292224, 2024.
Article in English | MEDLINE | ID: mdl-38108125

ABSTRACT

There has been a rapid increase in neonates born with a history of prenatal opioid exposure. How prenatal opioid exposure affects pain sensitivity in offspring is of interest, as this may perpetuate the opioid epidemic. While few studies have reported hypersensitivity to thermal pain, potential mechanisms have not been described. This study posits that alterations in the gut microbiome may underly hypersensitivity to pain in prenatally methadone-exposed 3-week-old male offspring, which were generated using a mouse model of prenatal methadone exposure. Fecal samples collected from dams and their offspring were subjected to 16s rRNA sequencing. Thermal and mechanical pain were assessed using the tail flick and Von Frey assays. Transcriptomic changes in whole brain samples of opioid or saline-exposed offspring were investigated using RNA-sequencing, and midbrain sections from these animals were subjected to qPCR profiling of genes related to neuropathic and inflammatory pain pathways. Prenatal methadone exposure increased sensitivity to thermal and mechanical pain and elevated serum levels of IL-17a. Taxonomical analysis revealed that prenatal methadone exposure resulted in significant alterations in fecal gut microbiota composition, including depletion of Lactobacillus, Bifidobacterium, and Lachnospiracea sp and increased relative abundance of Akkermansia, Clostridium sensu stricto 1, and Lachnoclostridium. Supplementation of the probiotic VSL#3 in dams rescued hypersensitivity to thermal and mechanical pain in prenatally methadone-exposed offspring. Similarly, cross-fostering prenatally methadone-exposed offspring to control dams also attenuated hypersensitivity to thermal pain in opioid-exposed offspring. Modulation of the maternal and neonatal gut microbiome with probiotics resulted in transcriptional changes in genes related to neuropathic and immune-related signaling in whole brain and midbrain samples of prenatally methadone-exposed offspring. Together, our work provides compelling evidence of the gut-brain-axis in mediating pain sensitivity in prenatally opioid-exposed offspring.


Subject(s)
Gastrointestinal Microbiome , Prenatal Exposure Delayed Effects , Humans , Pregnancy , Animals , Female , Male , Analgesics, Opioid/adverse effects , Gastrointestinal Microbiome/genetics , Dysbiosis/chemically induced , Dysbiosis/microbiology , RNA, Ribosomal, 16S/genetics , Prenatal Exposure Delayed Effects/microbiology , Methadone , Pain
8.
Microbiome ; 11(1): 165, 2023 07 27.
Article in English | MEDLINE | ID: mdl-37501202

ABSTRACT

BACKGROUND: During development, elevated levels of maternal glucocorticoids (GCs) can have detrimental effects on offspring morphology, cognition, and behavior as well as physiology and metabolism. Depending on the timing of exposure, such effects may vary in strength or even reverse in direction, may alleviate with age, or may concern more stable and long-term programming of phenotypic traits. Maternal effects on gut bacterial diversity, composition, and function, and the persistence of such effects into adulthood of long-lived model species in the natural habitats remain underexplored. RESULTS: In a cross-sectional sample of infant, juvenile, and adult Assamese macaques, the timing of exposure to elevated maternal GCs during ontogeny was associated with the gut bacterial community of the offspring. Specifically, naturally varying maternal GC levels during early but not late gestation or lactation were associated with reduced bacterial richness. The overall effect of maternal GCs during early gestation on the gut bacterial composition and function exacerbated with offspring age and was 10 times stronger than the effect associated with exposure during late prenatal or postnatal periods. Instead, variation in maternal GCs during the late prenatal or postnatal period had less pronounced or less stable statistical effects and therefore a weaker effect on the entire bacterial community composition, particularly in adult individuals. Finally, higher early prenatal GCs were associated with an increase in the relative abundance of several potential pro-inflammatory bacteria and a decrease in the abundance of Bifidobacterium and other anti-inflammatory taxa, an effect that exacerbated with age. CONCLUSIONS: In primates, the gut microbiota can be shaped by developmental effects with strong timing effects on plasticity and potentially detrimental consequences for adult health. Together with results on other macaque species, this study suggests potential detrimental developmental effects similar to rapid inflammaging, suggesting that prenatal exposure to high maternal GC concentrations is a common cause underlying both phenomena. Our findings await confirmation by metagenomic functional and causal analyses and by longitudinal studies of long-lived, ecologically flexible primates in their natural habitat, including developmental effects that originate before birth. Video Abstract.


Subject(s)
Gastrointestinal Microbiome , Prenatal Exposure Delayed Effects , Female , Animals , Pregnancy , Humans , Glucocorticoids , Gastrointestinal Microbiome/physiology , Cross-Sectional Studies , Primates , Bacteria/genetics , Prenatal Exposure Delayed Effects/microbiology
10.
Microbiome ; 10(1): 122, 2022 08 09.
Article in English | MEDLINE | ID: mdl-35941695

ABSTRACT

BACKGROUND: Hyperglycaemia in pregnancy (HIP) is a common metabolic disorder that not only poses risks to maternal health but also associates with an increased risk of diabetes among offspring. Vertical transmission of microbiota may influence the offspring microbiome and subsequent glucose metabolism. However, the mechanism by which maternal gut microbiota may influence glucose metabolism of the offspring remains unclear and whether intervening microbiota vertical transmission could be used as a strategy to prevent diabetes in the offspring of mothers with HIP has not been investigated. So we blocked vertical transmission to investigate its effect on glucose metabolism in the offspring. RESULTS: We established a murine HIP model with a high-fat diet (HFD) and investigated the importance of vertical transmission of gut microbiota on the glucose metabolism of offspring via birth and nursing by blocking these events through caesarean section (C-section) and cross-fostering. After weaning, all offspring were fed a normal diet. Based on multi-omics analysis, biochemical and transcriptional assays, we found that the glucometabolic deficits in the mothers were subsequently 'transmitted' to the offspring. Meanwhile, the partial change in mothers' gut microbial community induced by HIP could be transmitted to offspring, supported by the closed clustering of the microbial structure and composition between the offspring and their mothers. Further study showed that the microbiota vertical transmission was blocked by C-section and cross-fostering, which resulted in improved insulin sensitivity and islet function of the offspring of the mothers with HIP. These effects were correlated with changes in the relative abundances of specific bacteria and their metabolites, such as increased relative abundances of Bifidobacterium and short-chain fatty acids. In particular, gut microbial communities of offspring were closely related to those of their foster mothers but not their biological mothers, and the effect of cross-fostering on the offspring's gut microbiota was more profound than that of C-section. CONCLUSION: Our study demonstrates that the gut microbiota transmitted via birth and nursing are important contributors to the glucose metabolism phenotype in offspring. Video Abstract.


Subject(s)
Diabetes Mellitus , Gastrointestinal Microbiome , Hyperglycemia , Prenatal Exposure Delayed Effects , Animals , Cesarean Section , Diet, High-Fat/adverse effects , Female , Glucose , Humans , Mice , Pregnancy , Prenatal Exposure Delayed Effects/microbiology
11.
Brain Behav Immun ; 103: 186-201, 2022 07.
Article in English | MEDLINE | ID: mdl-35427758

ABSTRACT

Group B Streptococcus (GBS) remains a major neonatal life-threatening pathogen. We initially identified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a promising vaccine candidate against GBS. Since GAPDH is highly conserved, we investigate whether GBS GAPDH maternal vaccination interferes with the intestinal colonization of the offspring and the development of its mucosal immune system and central nervous system. An altered gut microbiome with increased Proteobacteria is observed in pups born from vaccinated dams during early life. These pups present decreased relative expression of IL-1ß, IL-17A, RegIIIγ and MUC2 in the distal colon. They also display increased CD11b, F4/80 and MHC class II expression on microglia in early life and marked reduction of Ly6C+ cells and neutrophils. Importantly, male mice born from vaccinated mothers present behavioral abnormalities during adulthood, including decreased exploratory behavior, a subtle anxious-like phenotype and global alterations in spatial learning and memory strategies, and higher sensitivity to a stressful stimulus. Our study highlights the danger of using ubiquitous antigens in maternal human vaccines against neonatal pathogens.


Subject(s)
Dysbiosis , Gastrointestinal Microbiome , Prenatal Exposure Delayed Effects , Streptococcal Vaccines , Animals , Dysbiosis/chemically induced , Female , Glyceraldehyde-3-Phosphate Dehydrogenases/genetics , Male , Mice , Pregnancy , Prenatal Exposure Delayed Effects/microbiology , Streptococcal Vaccines/adverse effects , Streptococcus agalactiae , Vaccination
12.
Immunity ; 55(1): 145-158.e7, 2022 01 11.
Article in English | MEDLINE | ID: mdl-34879222

ABSTRACT

Children with autism spectrum disorders often display dysregulated immune responses and related gastrointestinal symptoms. However, the underlying mechanisms leading to the development of both phenotypes have not been elucidated. Here, we show that mouse offspring exhibiting autism-like phenotypes due to prenatal exposure to maternal inflammation were more susceptible to developing intestinal inflammation following challenges later in life. In contrast to its prenatal role in neurodevelopmental phenotypes, interleukin-17A (IL-17A) generated immune-primed phenotypes in offspring through changes in the maternal gut microbiota that led to postnatal alterations in the chromatin landscape of naive CD4+ T cells. The transfer of stool samples from pregnant mice with enhanced IL-17A responses into germ-free dams produced immune-primed phenotypes in offspring. Our study provides mechanistic insights into why children exposed to heightened inflammation in the womb might have an increased risk of developing inflammatory diseases in addition to neurodevelopmental disorders.


Subject(s)
Autism Spectrum Disorder/immunology , CD4-Positive T-Lymphocytes/immunology , Chromatin/metabolism , Gastrointestinal Microbiome/immunology , Inflammation/immunology , Interleukin-17/metabolism , Intestines/immunology , Neurodevelopmental Disorders/immunology , Prenatal Exposure Delayed Effects/immunology , Animals , Autism Spectrum Disorder/microbiology , Child , Disease Models, Animal , Fecal Microbiota Transplantation , Female , Humans , Immunization , Inflammation/microbiology , Mice , Neurodevelopmental Disorders/microbiology , Pregnancy , Prenatal Exposure Delayed Effects/microbiology
13.
Nat Commun ; 12(1): 6289, 2021 11 01.
Article in English | MEDLINE | ID: mdl-34725359

ABSTRACT

Newborns are colonized by maternal microbiota that is essential for offspring health and development. The composition of these pioneer communities exhibits individual differences, but the importance of this early-life heterogeneity to health outcomes is not understood. Here we validate a human microbiota-associated model in which fetal mice are cesarean delivered and gavaged with defined human vaginal microbial communities. This model replicates the inoculation that occurs during vaginal birth and reveals lasting effects on offspring metabolism, immunity, and the brain in a community-specific manner. This microbial effect is amplified by prior gestation in a maternal obesogenic or vaginal dysbiotic environment where placental and fetal ileum development are altered, and an augmented immune response increases rates of offspring mortality. Collectively, we describe a translationally relevant model to examine the defined role of specific human microbial communities on offspring health outcomes, and demonstrate that the prenatal environment dramatically shapes the postnatal response to inoculation.


Subject(s)
Gastrointestinal Microbiome , Maternal-Fetal Relations/physiology , Microbiota , Parturition/physiology , Prenatal Exposure Delayed Effects/microbiology , Vagina/microbiology , Animals , Cesarean Section/methods , Female , Humans , Infant, Newborn , Male , Mice , Mice, Inbred C57BL , Pregnancy , Prenatal Exposure Delayed Effects/immunology , Prenatal Exposure Delayed Effects/pathology , Transcriptome
14.
FASEB J ; 35(11): e21971, 2021 11.
Article in English | MEDLINE | ID: mdl-34653284

ABSTRACT

It has been recently recognized that prenatal androgen exposure is involved in the development of polycystic ovary syndrome (PCOS) in adulthood. In addition, the gut microbiome in adult patients and rodents with PCOS differs from that of healthy individuals. Moreover, recent studies have suggested that the gut microbiome may play a causative role in the pathogenesis of PCOS. We wondered whether prenatal androgen exposure induces gut microbial dysbiosis early in life and is associated with the development of PCOS in later life. To test this hypothesis, we studied the development of PCOS-like phenotypes in prenatally androgenized (PNA) female mice and compared the gut microbiome of PNA and control offspring from 4 to 16 weeks of age. PNA offspring showed a reproductive phenotype from 6 weeks and a metabolic phenotype from 12 weeks of age. The α-diversity of the gut microbiome of the PNA group was higher at 8 weeks and lower at 12 and 16 weeks of age, and the ß-diversity differed from control at 8 weeks. However, a significant difference in the composition of gut microbiome between the PNA and control groups was already apparent at 4 weeks. Allobaculum and Roseburia were less abundant in PNA offspring, and may therefore be targets for future interventional studies. In conclusion, abnormalities in the gut microbiome appear as early as or even before PCOS-like phenotypes develop in PNA mice. Thus, the gut microbiome in early life is a potential target for the prevention of PCOS in later life.


Subject(s)
Androgens/metabolism , Gastrointestinal Microbiome , Polycystic Ovary Syndrome , Prenatal Exposure Delayed Effects/microbiology , Animals , Female , Male , Mice , Mice, Inbred C57BL , Polycystic Ovary Syndrome/metabolism , Polycystic Ovary Syndrome/microbiology , Pregnancy
15.
Sci Rep ; 11(1): 18971, 2021 09 23.
Article in English | MEDLINE | ID: mdl-34556804

ABSTRACT

Intra-amniotic infection (IAI) is a major cause of preterm birth with a poor perinatal prognosis. We aimed to determine whether analyzing vaginal microbiota can evaluate the risk of chorioamnionitis (CAM) in preterm labor cases. Vaginal discharge samples were collected from 83 pregnant women admitted for preterm labor. Based on Blanc's classification, the participants were divided into CAM (stage ≥ II; n = 46) and non-CAM (stage ≤ I; n = 37) groups. The 16S rDNA amplicons (V1-V2) from vaginal samples were sequenced and analyzed. Using a random forest algorithm, the bacterial species associated with CAM were identified, and a predictive CAM (PCAM) scoring method was developed. The α diversity was significantly higher in the CAM than in the non-CAM group (P < 0.001). The area under the curve was 0.849 (95% confidence interval 0.765-0.934) using the PCAM score. Among patients at < 35 weeks of gestation, the PCAM group (n = 22) had a significantly shorter extended gestational period than the non-PCAM group (n = 25; P = 0.022). Multivariate analysis revealed a significant difference in the frequency of developmental disorders in 3-year-old infants (PCAM, 28%, non-PCAM, 4%; P = 0.022). Analyzing vaginal microbiota can evaluate the risk of IAI. Future studies should establish appropriate interventions for IAI high-risk patients to improve perinatal prognosis.


Subject(s)
Chorioamnionitis/epidemiology , Developmental Disabilities/epidemiology , Microbiota/immunology , Prenatal Exposure Delayed Effects/epidemiology , Vagina/microbiology , Adult , Child, Preschool , Chorioamnionitis/immunology , Chorioamnionitis/microbiology , DNA, Bacterial/isolation & purification , Developmental Disabilities/immunology , Developmental Disabilities/microbiology , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Male , Obstetric Labor, Premature/immunology , Obstetric Labor, Premature/microbiology , Pilot Projects , Pregnancy , Prenatal Exposure Delayed Effects/immunology , Prenatal Exposure Delayed Effects/microbiology , RNA, Ribosomal, 16S/genetics , Risk Assessment/methods , Vagina/immunology
16.
Expert Opin Drug Metab Toxicol ; 17(10): 1165-1174, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34435921

ABSTRACT

INTRODUCTION: The composition of microorganisms is closely related to human health. Antibiotic use during pregnancy may have adverse effects on the neonatal gut microbiome and subsequently affect infant health development, leading to childhood atopy and allergic diseases, intestinal, metabolic and brain disorders, and infection. AREAS COVERED: This review includes the effect of maternal antibiotic use during pregnancy on potential diseases in animals and human offspring. EXPERT OPINION: Exposure to antibiotics during pregnancy alters offspring outcomes. Alterations in the microbiome may potentially lower the risk of a range of problems and may also be a novel therapeutic target in children later in life.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Gastrointestinal Microbiome/drug effects , Prenatal Exposure Delayed Effects/physiopathology , Animals , Anti-Bacterial Agents/adverse effects , Child , Female , Humans , Infant , Infant, Newborn , Maternal Exposure/adverse effects , Pregnancy , Prenatal Exposure Delayed Effects/microbiology
17.
Behav Brain Res ; 414: 113471, 2021 09 24.
Article in English | MEDLINE | ID: mdl-34280459

ABSTRACT

The aromatic amino acid tryptophan (Trp) is a precursor for multiple metabolites that can steer proper immune and neurodevelopment as well as social behavior in later life. Dysregulation in the Trp metabolic pathways and abundance of Trp or its derivatives, including indoles, kynurenine (Kyn), and particularly serotonin, has been associated with behavioral deficits and neuropsychiatric disorders including autism spectrum disorders (ASD) and schizophrenia. Previously, we have shown that prenatal stress (PNS) alters placental Trp and serotonin, and reduces Trp-metabolizing members of the maternal colonic microbiota. Given that PNS also results in alterations in offspring neurodevelopment, behavior and immune function, we hypothesized that PNS affects Trp metabolism and transport in both the maternal and fetal compartments, and that these alterations continue into adolescence. We surmised that this is due to reductions in Trp-metabolizing microbes that would otherwise reduce the Trp pool under normal metabolic conditions. To test this, pregnant mice were exposed to a restraint stressor and gene expression of enzymes involved in Trp and serotonin metabolism were measured. Specifically, tryptophan 2,3-dioxygenase, aryl hydrocarbon receptor, and solute carrier proteins, were altered due to PNS both prenatally and postnatally. Additionally, Parasutterella and Bifidobacterium, which metabolize Trp in the gut, were reduced in both the dam and the offspring. Together, the reductions of Trp-associated microbes and concomitant dysregulation in Trp metabolic machinery in dam and offspring suggest that PNS-induced Trp metabolic dysfunction may mediate aberrant fetal neurodevelopment.


Subject(s)
Gastrointestinal Microbiome , Prenatal Exposure Delayed Effects/metabolism , Prenatal Exposure Delayed Effects/microbiology , Stress, Psychological/metabolism , Stress, Psychological/microbiology , Tryptophan/metabolism , Age Factors , Animals , Disease Models, Animal , Female , Mice , Mice, Inbred C57BL , Pregnancy
18.
Aging (Albany NY) ; 13(12): 16733-16748, 2021 06 28.
Article in English | MEDLINE | ID: mdl-34182544

ABSTRACT

Multiple exposures to anesthesia may increase the risk of cognitive impairment in young children. However, the mechanisms underlying this neurodevelopmental disorder remain elusive. In this study, we investigated alteration of the gut microbiota after multiple neonatal exposures to the anesthetic sevoflurane and the potential role of microbiota alteration on cognitive impairment using a young mice model. Multiple neonatal sevoflurane exposures resulted in obvious cognitive impairment symptoms and altered gut microbiota composition. Fecal transplantation experiments confirmed that alteration of the microbiota was responsible for the cognitive disorders in young mice. Microbiota profiling analysis identified microbial taxa that showed consistent differential abundance before and after fecal microbiota transplantation. Several of the differentially abundant taxa are associated with memory and/or health of the host, such as species of Streptococcus, Lachnospiraceae, and Pseudoflavonifractor. The results reveal that abnormal composition of the gut microbiota is a risk factor for cognitive impairment in young mice after multiple neonatal exposures to sevoflurane and provide insight into a potential therapeutic strategy for sevoflurane-related neurotoxicity.


Subject(s)
Cognitive Dysfunction/microbiology , Gastrointestinal Microbiome , Prenatal Exposure Delayed Effects/microbiology , Sevoflurane/adverse effects , Anesthesia , Animals , Anti-Bacterial Agents/pharmacology , Behavior, Animal , Feces/microbiology , Female , Gastrointestinal Microbiome/drug effects , Germ-Free Life , Mice, Inbred C57BL , Morris Water Maze Test , Pregnancy
19.
BMC Microbiol ; 21(1): 166, 2021 06 03.
Article in English | MEDLINE | ID: mdl-34082715

ABSTRACT

Antibiotic exposure during pregnancy will adversely affect the growth of offspring; however, this remains controversial and the mechanism is poorly understood. To study this phenomenon, we added ceftriaxone sodium to the drinking water of pregnant rats and continuously monitored the body weight of their offspring. The results showed that compared with the control group, the offspring exposed to antibiotics during pregnancy had a higher body weight up to 3 weeks old but had a lower body weight at 6 weeks old. To determine the role of the gut microbiota and its metabolites in the growth of offspring, we collected feces for sequencing and further established that the experimental group has a different composition ratio of dominant bacteria at 6 week old, among which S24-7 correlated negatively with body weight and the metabolites that correlated with body weight-related unique flora were L-Valine, L-Leucine, Glutaric acid, N-Acetyl-L-glutamate, and 5-Methylcytosine. To further explore how they affect the growth of offspring, we submitted these data to Kyoto Encyclopedia of Genes and Genomes website for relevant pathway analysis. The results showed that compared with the control, the following metabolic pathways changed significantly: Valine, leucine, and isoleucine biosynthesis; Protein digestion and absorption; and Mineral absorption. Therefore, we believe that our findings support the conclusion that ceftriaxone sodium exposure in pregnancy has a long-lasting adverse effect on the growth of offspring because of an imbalance of gut microbiota, especially S24-7, via different metabolic pathways.


Subject(s)
Anti-Bacterial Agents/adverse effects , Bacteroidetes/drug effects , Body Weight/drug effects , Ceftriaxone/adverse effects , Gastrointestinal Microbiome/drug effects , Maternal Exposure/adverse effects , Prenatal Exposure Delayed Effects/microbiology , Prenatal Exposure Delayed Effects/physiopathology , Animals , Bacteria/classification , Bacteria/drug effects , Bacteria/genetics , Bacteria/isolation & purification , Bacteroidetes/classification , Bacteroidetes/genetics , Bacteroidetes/isolation & purification , Female , Humans , Male , Pregnancy , Prenatal Exposure Delayed Effects/etiology , Prenatal Exposure Delayed Effects/genetics , Rats , Rats, Sprague-Dawley
20.
Nutrients ; 13(1)2021 Jan 11.
Article in English | MEDLINE | ID: mdl-33440675

ABSTRACT

The risk of recurrence of estrogen receptor-positive breast cancer remains constant, even 20 years after diagnosis. Recurrence may be more likely in patients pre-programmed for it already in the womb, such as in the daughters born to obese mothers. Maternal obesity persistently alters offspring's gut microbiota and impairs tumor immune responses. To investigate if the gut dysbiosis is linked to increased risk of mammary cancer recurrence in the offspring of obese rat dams, we fed adult offspring genistein which is known to have beneficial effects on the gut bacteria. However, the effects of genistein on breast cancer remain controversial. We found that genistein intake after tamoxifen response prevented the increased risk of local recurrence in the offspring of obese dams but had no effect on the control offspring. A significant increase in the abundance of inflammatory Prevotellaceae and Enterobacteriaceae, and a reduction in short-chain fatty acid producing Clostridiaceae was observed in the offspring of obese dams. Genistein supplementation reversed these changes as well as reversed increased gut metabolite N-acetylvaline levels which are linked to increased all-cause mortality. Genistein supplementation also reduced genotoxic tyramine levels, increased metabolites improving pro-resolving phase of inflammation, and reversed the elevated tumor mRNA expression of multiple immunosuppressive genes in the offspring of obese dams. If translatable to breast cancer patients, attempts to prevent breast cancer recurrences might need to focus on dietary modifications which beneficially modify the gut microbiota.


Subject(s)
Gastrointestinal Microbiome/drug effects , Genistein/pharmacology , Mammary Neoplasms, Animal/microbiology , Obesity/microbiology , Prenatal Exposure Delayed Effects/microbiology , Animals , Female , Mammary Neoplasms, Animal/drug therapy , Obesity/etiology , Pregnancy , Prenatal Exposure Delayed Effects/etiology , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL